Economic evaluation of bariatric surgery to combat morbid obesity: a study from the West of Scotland

Muhammad Ali Karim, Edward Clifton, Jamil Ahmed, William MacKay, Abdulmajid Ali

Research output: Contribution to journalArticle

Abstract

INTRODUCTION: The increasing prevalence of obesity has now become a global concern. Forecasts of its health and financial ramifications have prompted the need for effective interventions. Bariatric surgery is an effective measure to control obesity and its related comorbidities, but its high up-front costs have raised questions about its cost-effectiveness. In this study we evaluated the health care-related direct cost savings after bariatric surgery.

METHODS: Data were prospectively obtained from patients who underwent bariatric surgery between May 2008 and April 2011, and a review was performed. These patients' annual cost of regular medications, hospital admissions and outpatient clinic visits were compared with the postoperative costs of these services. Data were collected from January 2005 to April 2012.

RESULTS: The analysis included 88 patients, 17 of whom were men and 71 were women. The procedures included 36 laparoscopic adjustable gastric banding, 33 sleeve gastrectomies and 19 Roux-en-Y gastric bypasses. All procedures were laparoscopic. Data were collected from patients during a median preoperative period of 60 months (range, 42-75 months) and a median postoperative period of 24 months (range, 12-45 moths). Annual savings were £11 452 on medications, £16 420 on hospital admissions and £2532 on outpatient clinic visits. Total annual savings were £30 404.

CONCLUSION: Given the rising prevalence of morbid obesity, bariatric surgery is a cost-effective treatment for morbid obesity and should be made available to morbidly obese patients.

Original languageEnglish
Pages (from-to)197-202
Number of pages6
JournalAsian Journal of Endoscopic Surgery
Volume6
Issue number3
DOIs
Publication statusPublished - Aug 2013

Fingerprint

Bariatric Surgery
Morbid Obesity
Scotland
Cost-Benefit Analysis
Ambulatory Care
Costs and Cost Analysis
Obesity
Hospital Outpatient Clinics
Preoperative Period
Gastric Bypass
Moths
Cost Savings
Gastrectomy
Ambulatory Care Facilities
Postoperative Period
Health Care Costs
Comorbidity
Stomach
Delivery of Health Care
Health

Keywords

  • Adult
  • Aged
  • Bariatric Surgery
  • Cost Savings
  • Cost-Benefit Analysis
  • Direct Service Costs
  • Female
  • Humans
  • Laparoscopy
  • Male
  • Middle Aged
  • Obesity, Morbid
  • Retrospective Studies
  • Scotland
  • Treatment Outcome

Cite this

@article{e6c0010bb16f4d30a5b530baf16e8ee1,
title = "Economic evaluation of bariatric surgery to combat morbid obesity: a study from the West of Scotland",
abstract = "INTRODUCTION: The increasing prevalence of obesity has now become a global concern. Forecasts of its health and financial ramifications have prompted the need for effective interventions. Bariatric surgery is an effective measure to control obesity and its related comorbidities, but its high up-front costs have raised questions about its cost-effectiveness. In this study we evaluated the health care-related direct cost savings after bariatric surgery.METHODS: Data were prospectively obtained from patients who underwent bariatric surgery between May 2008 and April 2011, and a review was performed. These patients' annual cost of regular medications, hospital admissions and outpatient clinic visits were compared with the postoperative costs of these services. Data were collected from January 2005 to April 2012.RESULTS: The analysis included 88 patients, 17 of whom were men and 71 were women. The procedures included 36 laparoscopic adjustable gastric banding, 33 sleeve gastrectomies and 19 Roux-en-Y gastric bypasses. All procedures were laparoscopic. Data were collected from patients during a median preoperative period of 60 months (range, 42-75 months) and a median postoperative period of 24 months (range, 12-45 moths). Annual savings were £11 452 on medications, £16 420 on hospital admissions and £2532 on outpatient clinic visits. Total annual savings were £30 404.CONCLUSION: Given the rising prevalence of morbid obesity, bariatric surgery is a cost-effective treatment for morbid obesity and should be made available to morbidly obese patients.",
keywords = "Adult, Aged, Bariatric Surgery, Cost Savings, Cost-Benefit Analysis, Direct Service Costs, Female, Humans, Laparoscopy, Male, Middle Aged, Obesity, Morbid, Retrospective Studies, Scotland, Treatment Outcome",
author = "Karim, {Muhammad Ali} and Edward Clifton and Jamil Ahmed and William MacKay and Abdulmajid Ali",
note = "{\circledC} 2013 Japan Society for Endoscopic Surgery, Asia Endosurgery Task Force and Wiley Publishing Asia Pty Ltd.",
year = "2013",
month = "8",
doi = "10.1111/ases.12042",
language = "English",
volume = "6",
pages = "197--202",
journal = "Asian Journal of Endoscopic Surgery",
issn = "1758-5902",
publisher = "Wiley",
number = "3",

}

Economic evaluation of bariatric surgery to combat morbid obesity : a study from the West of Scotland. / Karim, Muhammad Ali; Clifton, Edward; Ahmed, Jamil; MacKay, William; Ali, Abdulmajid.

In: Asian Journal of Endoscopic Surgery, Vol. 6, No. 3, 08.2013, p. 197-202.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Economic evaluation of bariatric surgery to combat morbid obesity

T2 - a study from the West of Scotland

AU - Karim, Muhammad Ali

AU - Clifton, Edward

AU - Ahmed, Jamil

AU - MacKay, William

AU - Ali, Abdulmajid

N1 - © 2013 Japan Society for Endoscopic Surgery, Asia Endosurgery Task Force and Wiley Publishing Asia Pty Ltd.

PY - 2013/8

Y1 - 2013/8

N2 - INTRODUCTION: The increasing prevalence of obesity has now become a global concern. Forecasts of its health and financial ramifications have prompted the need for effective interventions. Bariatric surgery is an effective measure to control obesity and its related comorbidities, but its high up-front costs have raised questions about its cost-effectiveness. In this study we evaluated the health care-related direct cost savings after bariatric surgery.METHODS: Data were prospectively obtained from patients who underwent bariatric surgery between May 2008 and April 2011, and a review was performed. These patients' annual cost of regular medications, hospital admissions and outpatient clinic visits were compared with the postoperative costs of these services. Data were collected from January 2005 to April 2012.RESULTS: The analysis included 88 patients, 17 of whom were men and 71 were women. The procedures included 36 laparoscopic adjustable gastric banding, 33 sleeve gastrectomies and 19 Roux-en-Y gastric bypasses. All procedures were laparoscopic. Data were collected from patients during a median preoperative period of 60 months (range, 42-75 months) and a median postoperative period of 24 months (range, 12-45 moths). Annual savings were £11 452 on medications, £16 420 on hospital admissions and £2532 on outpatient clinic visits. Total annual savings were £30 404.CONCLUSION: Given the rising prevalence of morbid obesity, bariatric surgery is a cost-effective treatment for morbid obesity and should be made available to morbidly obese patients.

AB - INTRODUCTION: The increasing prevalence of obesity has now become a global concern. Forecasts of its health and financial ramifications have prompted the need for effective interventions. Bariatric surgery is an effective measure to control obesity and its related comorbidities, but its high up-front costs have raised questions about its cost-effectiveness. In this study we evaluated the health care-related direct cost savings after bariatric surgery.METHODS: Data were prospectively obtained from patients who underwent bariatric surgery between May 2008 and April 2011, and a review was performed. These patients' annual cost of regular medications, hospital admissions and outpatient clinic visits were compared with the postoperative costs of these services. Data were collected from January 2005 to April 2012.RESULTS: The analysis included 88 patients, 17 of whom were men and 71 were women. The procedures included 36 laparoscopic adjustable gastric banding, 33 sleeve gastrectomies and 19 Roux-en-Y gastric bypasses. All procedures were laparoscopic. Data were collected from patients during a median preoperative period of 60 months (range, 42-75 months) and a median postoperative period of 24 months (range, 12-45 moths). Annual savings were £11 452 on medications, £16 420 on hospital admissions and £2532 on outpatient clinic visits. Total annual savings were £30 404.CONCLUSION: Given the rising prevalence of morbid obesity, bariatric surgery is a cost-effective treatment for morbid obesity and should be made available to morbidly obese patients.

KW - Adult

KW - Aged

KW - Bariatric Surgery

KW - Cost Savings

KW - Cost-Benefit Analysis

KW - Direct Service Costs

KW - Female

KW - Humans

KW - Laparoscopy

KW - Male

KW - Middle Aged

KW - Obesity, Morbid

KW - Retrospective Studies

KW - Scotland

KW - Treatment Outcome

U2 - 10.1111/ases.12042

DO - 10.1111/ases.12042

M3 - Article

VL - 6

SP - 197

EP - 202

JO - Asian Journal of Endoscopic Surgery

JF - Asian Journal of Endoscopic Surgery

SN - 1758-5902

IS - 3

ER -